Viking Therapeutics to Participate at Upcoming Investor Conferences
Rhea-AI Summary
Viking Therapeutics (VKTX) will participate in three September 2026 healthcare investor events: the Cantor Global Healthcare Conference, the Morgan Stanley 24th Annual Global Healthcare Conference, and the Bernstein 3rd Annual Healthcare Forum, all held in New York, NY.
Viking management will join fireside chats and investor meetings at each conference. The Cantor fireside chat is scheduled for September 11, the Morgan Stanley session for September 14 with a live webcast and replay via Viking’s website, and the Bernstein session for September 23.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Details of the company's participation are as follows:
- 2026 Cantor Global Healthcare Conference
Details: Viking management will participate in a fireside chat and investor meetings.
Conference Dates: September 9-11, 2026
Fireside Chat Date/Time: Friday, September 11th at 10:20 am 10:50 am ET
Location:New York, NY
- Morgan Stanley 24th Annual Global Healthcare Conference
Details: Viking management will participate in a fireside chat and investor meetings.
Conference Dates: September 14-16, 2026
Fireside Chat Date/Time: Monday, September 14th at 3:20 pm – 3:55 pm ET
Location:New York, NY
Webcast available
- Bernstein 3rd Annual Healthcare Forum
Details: Viking management will participate in a fireside chat and investor meetings.
Conference Dates: September 23-24, 2026
Fireside Chat Date/Time: Wednesday, September 23rd at 10:30 am – 11:10 am ET
Location:New York, NY
A live webcast of the Morgan Stanley fireside chat may be accessed via a link on the Viking Therapeutics website in the Investors & Media section under Webcasts. Additionally, a replay of the webcast will be available on the Viking website following the conference.
About Viking Therapeutics, Inc.
Viking Therapeutics, Inc. is a clinical-stage biotechnology company advancing a next-generation portfolio of therapies for obesity and metabolic disease. Guided by deep expertise in metabolic biology and rigorous science, Viking is developing innovative treatments to help people achieve meaningful, lasting health improvements by treating obesity first. The company's lead program, VK2735, is a dual glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist in development in both subcutaneous and oral formulations for obesity. VK2735 is currently being evaluated in Phase 3 clinical studies for obesity, along with maintenance dosing strategies designed to support long-term weight management. Viking is also advancing additional obesity programs, including VK3019, an amylin receptor agonist, VK2809, an orally available thyroid hormone receptor beta agonist for metabolic and liver disease, and VK0214 for the rare genetic disorder X-linked adrenoleukodystrophy (X-ALD).
For more information about Viking Therapeutics, please visit www.vikingtherapeutics.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/viking-therapeutics-to-participate-at-upcoming-investor-conferences-302867002.html
SOURCE Viking Therapeutics, Inc.
FAQ
When will Viking Therapeutics (VKTX) present at the 2026 Cantor Global Healthcare Conference?
Viking Therapeutics will participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Friday, September 11, 2026, from 10:20 am to 10:50 am ET in New York, NY. Management will also hold investor meetings during the September 9–11 conference.
What are the details of Viking Therapeutics’ participation at the Morgan Stanley 24th Annual Global Healthcare Conference 2026?
At the Morgan Stanley 24th Annual Global Healthcare Conference, held September 14–16, 2026 in New York, Viking management will join a fireside chat on Monday, September 14 from 3:20 pm to 3:55 pm ET and conduct investor meetings. A live webcast and replay will be available via Viking’s website.
How can investors access the Viking Therapeutics (VKTX) Morgan Stanley conference webcast?
Investors can access the live webcast of Viking Therapeutics’ Morgan Stanley fireside chat through a link on the company’s website, in the Investors & Media section under Webcasts. A replay of the webcast will also be available on the Viking website after the conference.
When is Viking Therapeutics’ fireside chat at the Bernstein 3rd Annual Healthcare Forum 2026?
Viking Therapeutics will participate in a fireside chat at the Bernstein 3rd Annual Healthcare Forum on Wednesday, September 23, 2026, from 10:30 am to 11:10 am ET in New York, NY. The forum runs from September 23–24, 2026 and will also include investor meetings.
Which investor conferences will Viking Therapeutics (VKTX) attend in September 2026?
In September 2026, Viking Therapeutics will attend three New York events: the 2026 Cantor Global Healthcare Conference (September 9–11), the Morgan Stanley 24th Annual Global Healthcare Conference (September 14–16), and the Bernstein 3rd Annual Healthcare Forum (September 23–24).